Difficulty: Medium
Average Score: 71%
Practice
A 21-year-old woman suffering from seasonal allergic conjunctivitis started a treatment with eye drops of azelastine, a second-generation histamine H1 antagonist. Second-generation H1 antagonists are used locally in the conjunctiva instead of first-generation H1 antagonists to provide which of the following therapeutic advantages?
Correct answer
A
Rationale
The correct answer is A) Negligible effects on pupil size and accommodation. Second-generation H1 antagonists like azelastine are preferred for local use in the conjunctiva over first-generation H1 antagonists due to their selective action on histamine receptors in the target tissue, which leads to reduced systemic side effects.
Option B) Negligible penetration into the central nervous system is incorrect because second-generation H1 antagonists still have the potential to enter the systemic circulation and reach the central nervous system, albeit in lower amounts compared to first-generation drugs.
Option C) Higher dilating activity on conjunctival vessels is incorrect as second-generation H1 antagonists are chosen for their lower affinity for blood vessels in the conjunctiva, leading to reduced risk of vascular dilation and subsequent redness.
Option D) Higher blocking activity on lacrimal gland secretion is incorrect because second-generation H1 antagonists are not selected for their increased blocking activity on lacrimal gland secretion but rather for their reduced impact on pupil size and accommodation.
In an educational context, understanding the differences between first and second-generation H1 antagonists is crucial for healthcare professionals to make informed decisions when prescribing medications for conditions like allergic conjunctivitis. Second-generation drugs offer a more targeted approach with fewer systemic side effects, making them a preferred choice for local treatment in sensitive areas like the eye.
Option B) Negligible penetration into the central nervous system is incorrect because second-generation H1 antagonists still have the potential to enter the systemic circulation and reach the central nervous system, albeit in lower amounts compared to first-generation drugs.
Option C) Higher dilating activity on conjunctival vessels is incorrect as second-generation H1 antagonists are chosen for their lower affinity for blood vessels in the conjunctiva, leading to reduced risk of vascular dilation and subsequent redness.
Option D) Higher blocking activity on lacrimal gland secretion is incorrect because second-generation H1 antagonists are not selected for their increased blocking activity on lacrimal gland secretion but rather for their reduced impact on pupil size and accommodation.
In an educational context, understanding the differences between first and second-generation H1 antagonists is crucial for healthcare professionals to make informed decisions when prescribing medications for conditions like allergic conjunctivitis. Second-generation drugs offer a more targeted approach with fewer systemic side effects, making them a preferred choice for local treatment in sensitive areas like the eye.